FDA CDER assigned for pre-market review of CorMedix’s Neutrolin – News-Medical.Net

“We look forward to working with CDER’s anti-infective products group at the FDA in the development of Neutrolin” The Company will request a pre-Investigational New Drug (“pre-IND”) meeting with the FDA in preparation of filing an …